canan g. nebigil
INSERM U1260 Nanomedicine régénératrice (RNM)
Strasbourg, France
Associate Editor
Cardio-Oncology
INSERM U1260 Nanomedicine régénératrice (RNM)
Strasbourg, France
Associate Editor
Cardio-Oncology
Haukeland University Hospital
Bergen, Norway
Associate Editor
Surgical Oncology
Peter MacCallum Cancer Centre
Melbourne, Australia
Associate Editor
Cancer Immunity and Immunotherapy
University of Colorado Denver
Denver, United States
Associate Editor
Cancer Immunity and Immunotherapy
University of Siena
Siena, Italy
Associate Editor
Breast Cancer
University of Pisa
Pisa, Italy
Associate Editor
Cancer Imaging and Image-directed Interventions
Unit of Cancer Gynaecology, Department of Woman and Child Health and Public Health, Agostino Gemelli University Polyclinic (IRCCS)
Rome, Italy
Associate Editor
Gynecological Oncology
University of Milano-Bicocca
Milan, Italy
Associate Editor
Surgical Oncology
Massachusetts General Hospital, Harvard Medical School
Boston, United States
Associate Editor
Radiation Oncology
University of Innsbruck
Innsbruck, Austria
Associate Editor
Molecular and Cellular Oncology
Faculty of Medicine, RWTH Aachen University
Aachen, Germany
Associate Editor
Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Singapore Immunology Network (A*STAR)
Singapore, Singapore
Associate Editor
Cancer Immunity and Immunotherapy
The Chinese University of Hong Kong
Shatin, China
Associate Editor
Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
The Chinese University of Hong Kong
Shatin, China
Associate Editor
Pharmacology of Anti-Cancer Drugs
Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong
Kowloon, Hong Kong, SAR China
Associate Editor
Head and Neck Cancer
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Cambridge, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs